Cantú-Brito C, Chiquete E, Duarte-Vega M, Rubio-Guerra A, Herrera-Cornejo M, Nettel-García J

Idioma: Español
Referencias bibliográficas: 19
Paginas: 239-246
Archivo PDF: 52.78 Kb.

RESUMEN

Introducción: la enfermedad arterial periférica (EAP) está asociada con elevada morbimortalidad cardiovascular por aterosclerosis. El objetivo de esta investigación fue conocer la prevalencia de EAP y sus factores determinantes en la población mexicana.
Métodos: determinación del índice tobillo-brazo (ITB) mediante Doppler en población con alto riesgo para EAP. Se consideró un ITB ≤ 0.9 como indicador de EAP. El ITB › 1.3 se consideró indicador indirecto de calcificación y rigidez arterial.
Resultados: de 5101 pacientes, 1212 (23.8 %) tuvieron ITB ≤ 0.9 y 431 (8.4 %) ITB › 1.3 (incluyendo 1 % con arterias incompresibles). Los factores asociados con ITB ≤ 0.9 fueron la edad, la hipertensión arterial, la diabetes mellitus, el tabaquismo, la dislipidemia y el antecedente de eventos vasculares. El ITB › 1.3 se asoció con la edad, el sexo masculino, la diabetes mellitus, el tabaquismo previo y el antecedente de eventos vasculares. Una proporción elevada de pacientes con vasculopatía periférica identificada por el ITB ≤ 0.9 manifestó pocos o ningún síntoma.
Conclusiones: existe elevada prevalencia de ITB anormal en la población mexicana portadora de factores de riesgo vascular. La medición del ITB puede ayudar a identificar a los pacientes que precisan intensificación de la prevención secundaria y de tratamiento más agresivo.

REFERENCIAS (EN ESTE ARTÍCULO)

1. López AD, Mathers CD, Ezzati M, Kamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367(9524):1747-1757.

2. 2 Rosamond W, Flegal K, Furie K, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117(4):e25-e146.

3. Meaney E, Lara-Esqueda A, Ceballos-Reyes GM, et al. Cardiovascular risk factors in the urban Mexican population: the FRIMEX study. Public Health 2007;121:378-384.

4. Agnelli G, Cimminiello C, Meneghetti G, Urbinati S; Polyvascular Atherothrombosis Observational Survey (PATHOS) Investigators. Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events. J Thromb Haemost 2006;4(12): 2599-2606.

5. Belch JJ, Topol EJ, Agnelli G, et al. Prevention of atherothrombotic disease network. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 2003;163:884-892.

6. Coccheri S; CAPRIE Investigators. Distribution of symptomatic atherothrombosis and influence of the atherosclerotic disease burden on risk of secondary ischemic events: results from CAPRIE. Eur Heart J 1998;19: 1268.

7. Bhatt DL, Steg PG, Ohman EM, et al; REACH Registry Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006;295(2):180-189.

8. Guo X, Li J, Pang W, Zhao M, Luo Y, Sun Y, Hu D. Sensitivity and specificity of ankle-brachial index for detecting angiographic stenosis of peripheral arteries. Circ J 2008; 72(4):605-610.

9. Holland-Letz T, Endres HG, Biedermann S, et al. Reproducibility and reliability of the ankle-brachial index as assessed by vascular experts, family physicians and nurses. Vasc Med. 2007;12(2):105-12.

10. Olin JW, Allie DE, Belkin M, Bonow RO, et al. 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on perfor mance measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease). Circulation 2010;122(24): 2583-2618.

11. Greenland P, Abrams J, Aurigemma GP, et al. Prevention Conference V. Beyond secondary prevention: Identifying the high-risk patient for primary prevention. Noninvasive tests of atherosclerotic burden. Circulation 2000;101(1):E16-E22.

12. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997;26(3):517-538.

13. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286(11):1317-1324.

14. Bozkurt AK, Tasci I, Tabak O, Gumus M, Kaplan Y. Peripheral artery disease assessed by ankle-brachial index in patients with established cardiovascular disease or at least one risk factor for atherothrombosis. CAREFUL Study: a national, multi-center, cross-sectional observational study. BMC Cardiovasc Disord 2011;11:4.

15. Ferreira AC, Macedo FY. A review of simple, non-invasive means of assessing peripheral arterial disease and implications for medical management. Ann Med 2010; 42(2): 139-50.

16. Newman AB, Siscovick DS, Manolio TA; the Cardiovascular Health Study (CHS) Collaborative Research Group. Ankle- Arm Index as a Marker of Atherosclerosis in the Cardiovascular Health Study. Circulation 1993;88(3): 837-845.

17. Diehm C, Lange S, Darius H, et al. Association of low ankle brachial index with high mortality in primary care. Eur Heart J 2006;27(14):1743-1749.

18. Álvarez J, Gil A, Quintana M. Prevalencia de enfermedad arterial periférica asintomática en pacientes con ICTUS isquémico no cardioembólico. Neurologia 2009; 24(6):366-372.

19. Resnick HE, Lindsay RS, McDermott MM, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 2004;109(6):733-739.